Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1H)-Carboxamide as a Novel JNK Inhibitor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Miyoung | - |
dc.contributor.author | Oh, Youri | - |
dc.contributor.author | Cho, Hyunwook | - |
dc.contributor.author | Yang, Songyi | - |
dc.contributor.author | Moon, Hyungwoo | - |
dc.contributor.author | Im, Daseul | - |
dc.contributor.author | Hah, Jung-Mi | - |
dc.date.accessioned | 2021-06-22T09:07:24Z | - |
dc.date.available | 2021-06-22T09:07:24Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2020-03 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/1254 | - |
dc.description.abstract | We designed and synthesized 1-pyrimidinyl-2-aryl-4, 6-dihydropyrrolo [3,4-d] imidazole-5(1H)-carboxamide derivatives as selective inhibitors of c-Jun-N-terminal Kinase 3 (JNK3), a target for the treatment of neurodegenerative diseases. Based on the compounds found in previous studies, a novel scaffold was designed to improve pharmacokinetic characters and activity, and compound 18a, (R)-1-(2-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)amino)pyrimidin-4-yl)-2-(3,4-dichlorophenyl)-4,6-dihydro pyrrolo [3,4-d]imidazole-5(1H)-carboxamide, showed the highest IC50 value of 2.69 nM. Kinase profiling results also showed high selectivity for JNK3 among 38 kinases, having mild activity against JNK2, RIPK3, and GSK3 beta, which also known to involve in neuronal apoptosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1H)-Carboxamide as a Novel JNK Inhibitor | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hah, Jung-Mi | - |
dc.identifier.doi | 10.3390/ijms21051698 | - |
dc.identifier.scopusid | 2-s2.0-85081156527 | - |
dc.identifier.wosid | 000524908500149 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.21, no.5, pp.1 - 17 | - |
dc.relation.isPartOf | International Journal of Molecular Sciences | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 21 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 17 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | TERMINAL KINASE INHIBITORS | - |
dc.subject.keywordPlus | JUN | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | NECROPTOSIS | - |
dc.subject.keywordAuthor | JNK | - |
dc.subject.keywordAuthor | RIPK | - |
dc.subject.keywordAuthor | imidazole | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | SAR | - |
dc.identifier.url | https://www.mdpi.com/1422-0067/21/5/1698 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.